Cargando…
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France
BACKGROUND: Hereditary angioedema (HAE) is associated with a heavy burden of illness. OBJECTIVE: To evaluate use of lanadelumab in a French Authorization for Temporary Use (ATU) program. METHODS: ATU requests were made between October 12, 2018, and March 13, 2019; patients were followed through Sept...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976389/ https://www.ncbi.nlm.nih.gov/pubmed/35365234 http://dx.doi.org/10.1186/s13223-022-00664-4 |